ArticleTherapeutic advances in chronic disease2022

First-line therapeutic strategy for patients with advanced non-small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis.

Chongxiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.